SECURITIES AND EXCHANGE COMMISSION FORM 8-K

First Page		Document Content
Date: 2012-06-03 08:54:50 Asuragen United States securities law Norwalk Connecticut Information Small interfering RNA Copyright Securities Act Business Technology Applied Biosystems Applera Celera Corporation		SECURITIES AND EXCHANGE COMMISSION FORM 8-K Add to Reading List Source URL: pdf.secdatabase.com Download Document from Source Website File Size: 158,08 KB Share Document on Facebook

	Metadata Specifications: Nucleic Acid Reagents Custom Fields Common Fields DocID: 1qMlu - View Document
	Free Radical Biology and Medicine–1515 Contents lists available at ScienceDirect Free Radical Biology and Medicine journal homepage: www.elsevier.com/locate/freeradbiomed DocID: 1qf2g - View Document
	LINCS_DWG_siRNAshRNAReagents_MetaData_Release_JulLINCS standardized siRNA and shRNA information Unique ID LINCS Field Name DocID: 1pTkZ - View Document
	REVIEWS TARGETS Vol. 1, No. 1 July 2002 TECHNICAL FOCUS DocID: 1puAm - View Document
	Oligonucleotide Conjugates with enhanced cellular uptake Gene therapy by delivery of DNA or RNA oligonucleotides to cells is a highly promising technology, but various technical obstacles need to be overcome before it ca DocID: 1p2uc - View Document